SynthesisThe New England journal of medicine2017

20-Year Risks of Breast-Cancer Recurrence after Stopping Endocrine Therapy at 5 Years.

Hongchao Pan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.